The bill introduces new endorsements for medical cannabis beverage production and import, sets fees, and defines related terms.
The Medical Cannabis Beverage Product Amendment Act of 2026 establishes new endorsements for medical cannabis beverage production and import. Licensed alcoholic beverage manufacturers can apply for a medical cannabis beverage production endorsement to produce and deliver medical cannabis beverages. The bill sets a $500 annual fee for this endorsement and requires compliance with testing, tracking, and reporting requirements.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.